Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Apogee Therapeutics Inc. (NASDAQ: APGE) closed at $46.95 down -3.00% from its previous closing price of $48.40. In other words, the price has decreased by -$3.00 from its previous closing price. On the day, 0.56 million shares were traded. APGE stock price reached its highest trading level at $48.61 during the session, while it also had its lowest trading level at $46.64.
Ratios:
For a deeper understanding of Apogee Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 27.70 and its Current Ratio is at 27.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on May 10, 2024, initiated with a Buy rating and assigned the stock a target price of $80.
On December 20, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $43.
On August 08, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $40.Wedbush initiated its Outperform rating on August 08, 2023, with a $40 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 04 ’24 when HENDERSON MICHAEL THOMAS bought 40,000 shares for $47.62 per share.
Henderson Jane sold 6,000 shares of APGE for $289,560 on Aug 23 ’24. The Chief Financial Officer now owns 200,871 shares after completing the transaction at $48.26 per share. On Aug 23 ’24, another insider, JANE V HENDERSON, who serves as the Officer of the company, bought 6,000 shares for $48.26 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APGE now has a Market Capitalization of 2661172992 and an Enterprise Value of 2158563072.
Stock Price History:
Over the past 52 weeks, APGE has reached a high of $72.29, while it has fallen to a 52-week low of $14.19. The 50-Day Moving Average of the stock is 4.20%, while the 200-Day Moving Average is calculated to be 11.07%.
Shares Statistics:
For the past three months, APGE has traded an average of 441.46K shares per day and 322710 over the past ten days. A total of 37.17M shares are outstanding, with a floating share count of 37.12M. Insiders hold about 36.53% of the company’s shares, while institutions hold 76.98% stake in the company. Shares short for APGE as of 1723680000 were 8185424 with a Short Ratio of 18.54, compared to 1721001600 on 8612212. Therefore, it implies a Short% of Shares Outstanding of 8185424 and a Short% of Float of 21.290001.
